欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2612/001
药品名称
Oxaliplatina Hikma
活性成分
oxaliplatin 5.0 mg/ml
剂型
Concentrate for solution for infusion
上市许可持有人
Hikma Farmacêutica (Portugal), S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Oxaliplatin Hikma 5 mg/ml Konzentrag zur >herstellung einer Infusionslösung
Netherlands (NL)
Oxaliplatine Hikma 5 mg/ml concentraat voor oplossing voor infusie
Austria (AT)
France (FR)
Spain (ES)
Italy (IT)
United Kingdom (Northern Ireland) (XI)
许可日期
2021/07/13
最近更新日期
2023/08/01
药物ATC编码
L01XA03 oxaliplatin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
653784_20220313_PAR_MSP
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase